Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota
International Journal of Molecular Sciences · 10.02.2025 · 26 (4) · 1470
DOI: 10.3390/ijms26041470 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.02.2025. Verfasst von Guoquan Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Inner Mongolia Agricultural University, Hohhot 010018, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Polysaccharides, Diabetic Nephropathies, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Inner Mongolia Innovation Team Development Program, Natural Science Foundation of Inner Mongolia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
We aimed to uncover the underlying mechanisms contributing to the therapeutic efficacy of Astragalus mongholicus Polysaccharides (mAPS) in alleviating diabetic nephropathy (DN). The rat model of DN was subjected to a high-sugar and high-fat diet (HSHFD) coupled with streptozotocin (STZ) injection. Our findings revealed that mAPS administration decreased fasting blood glucose (FBG), BUN, SCR, UA, and MDA levels, while elevating serum GSH, GSH-PX, and SOD activities in DN rats (p < 0.05). Furthermore, there was a notable rise in the mRNA and protein expression of renal Nrf-2, GCLC, NQO1, and HO-1 post mAPS treatment (p < 0.05). Additionally, mAPS supplementation led to reduced protein expression of TLR4, NLRP3, p-NF-κB, TGF-β, and Smad4. Concurrently, mAPS exerted a modulatory effect on gut microbiota, as evidenced by the increased abundance of Muribaculaceae, Ruminococcus_1, Phascolarctobacterium, and Lachnoclostridium-related genera. Spearman correlation analysis illustrated a negative association between the abundance of microbiota (Muribaculaceae, Lachnospiraceae_NK4A136, Ruminococcus_1, Clostridiales) and the levels of serum parameters (BUN, CR, UA, TC, TG). In summary, our data robustly attests to the potential of mAPS in modulating oxidative stress, inflammation, and gut microbiota, ultimately resulting in improved renal function in DN rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Inner Mongolia Agricultural University, Hohhot 010018, China.
ORCID-Profile: Yuzhen Wang
Förderung
- National Natural Science Foundation of China
- Inner Mongolia Innovation Team Development Program
- Natural Science Foundation of Inner Mongolia
- Science and technology programs of Inner Mongolia
- Basic scientific research business of colleges and universities directly under the Inner Mongolia Autonomous Region
Zitieren
APA
Xu, G., Yuan, H., Liu, J., Wang, X., Ma, L., Wang, Y., & Dong, G. (2025). Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences, 26(4), 1470. https://doi.org/10.3390/ijms26041470
Vancouver
Xu G, Yuan H, Liu J, Wang X, Ma L, Wang Y, et al. Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences. 2025;26(4):1470. doi:10.3390/ijms26041470
BibTeX
@article{Xu2025,
author = {Xu, Guoquan and Yuan, Haisheng and Liu, Jingran and Wang, Xianjue and Ma, Li and Wang, Yuzhen and Dong, Guicheng},
title = {Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1470},
doi = {10.3390/ijms26041470}
}
EUVIMED